Allergic contact dermatitis: A commentary on the relationship between T lymphocytes and skin sensitising potency

Toxicology

Volumn 291, Issue 1-3, 2012, Pages 18-24

  Kimber, Ian ^a   Maxwell, Gavin ^b   Gilmour, Nicky ^b   Dearman, Rebecca J ^a   Friedmann, Peter S ^c   Martin, Stefan F ^d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNILEVER RESEARCH   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Alternative tests; Hazard characterisation; Skin sensitisation; T lymphocytes

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; CONTACT ALLERGEN; HAPTEN; INTERLEUKIN 10; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CLONAL ANERGY; EFFECTOR CELL; HEALTH HAZARD; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LOCAL LYMPH NODE ASSAY; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; RISK ASSESSMENT; SKIN ALLERGY; SKIN SENSITIZATION; T LYMPHOCYTE;

ANIMALS; DERMATITIS, ALLERGIC CONTACT; HUMANS; IMMUNIZATION; RISK ASSESSMENT; SAFETY MANAGEMENT; SKIN; T-LYMPHOCYTES;

EID: 84155162842     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2011.11.007     Document Type: Review

References (76)

1. + T cytotoxic cells inducing keratinocyte apoptosis. J. Immunol. 2002, 168:3079-3087.
2. + cells. Arthritis Res. Ther. 2009, 11:257.
3. Basketter D.A., Blaikie L., Dearman R.J., Kimber I., Ryan C.A., Gerberick G.F., Harvey P., Evans P., White I.R., Rycroft R.J.G. Use of the local lymph node assay for estimation of relative contact allergenic potency. Contact Dermat. 2000, 42:344-348.
4. Basketter D.A., Andersen K.E., Liden C., Van Loveren H., Boman A., Kimber I., Alanko K., Berggren E. Evaluation of the skin sensitizing potency of chemicals by using existing methods, and consideration of the relevance of elicitation. Contact Dermat. 2005, 52:39-43.
5. Basketter D.A., Clapp C., Jefferies D., Safford B., Ryan C.A., Gerberick F., Dearman R.J., Kimber I. Predictive identification of skin sensitization thresholds. Contact Dermat. 2005, 53:260-267.
6. Basketter D.A., Gerbercik G.F., Kimber I. The local lymph node assay and the assessment of relative potency: status of validation. Contact Dermat. 2007, 57:70-75.
7. Basketter D.A., Kimber I. Updating the skin sensitization in vitro data assessment paradigm in 2009. J. Appl. Toxicol. 2009, 29:545-550.
8. Basketter D.A., Lea L.J., Dickens A., Briggs D., Pate I., Dearman R.J., Kimber I. A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses. J. Appl. Toxicol. 1999, 19:261-266.
9. Basketter D.A., Maxwell G. In vitro approaches to the identification and characterization of skin sensitizers. Cutan. Ocul. Toxicol. 2007, 26:359-373.
10. + T cells, respectively, mediate and regulate contact sensiotivity to dinitrofluorobenzene. Eur. J. Immunol. 1995, 25:3006-3010.
11. Buehler E.V. Delayed contact hypersensitivity in the guinea pig. Arch. Dermatol. 1965, 91:171-177.
12. Cavani A. T regulatory cells in contact hypersensitivity. Curr. Opin. Allergy Clin. Immunol. 2008, 8:294-298.
13. Cavani A., Albanesi C., Traidl C., Sebastiani S., Girolomoni G. Effector and regulatory T cells in allergic contact dermatitis. Trends Immunol. 2001, 22:118-120.
14. + T cells. J. Invest. Dermatol. 1998, 111:621-628.
15. Dietz L., Esser P., Schmucker S.S., Goette I., Richter A., Schnotzer M., Martin S.F., Thierse H.J. Tracking human contact allergens: from mass spectrometric identification of peptide-bound reactive small chemicals to chemical-specific naive human T-cell priming. Toxicol. Sci. 2010, 177:236-247.
16. Friedmann P.S. The immunology of allergic contact dermatitis: the DNCB story. Adv. Dermatol. 1990, 5:175-196.
17. Friedmann P.S., Pickard C. Quantifying human susceptibility to contact sensitization; risk assessments now and in the future. Contact Dermat. 2010, 63:237-247.
18. Friedmann P.S., Rees J., White S.I., Matthews J.N. Low-dose exposure to antigen induces sub-clinical sensitization. Clin. Exp. Immunol. 1990, 81:507-509.
19. Galvao dos Santos G., Reinders J., Ouwehand K., Rustemeyer T., Scheper R.J., Gibbs S. Progress on the development of human dendritic cell based assays for assessment of the skin sensitizing potential of a compound. Toxicol. Appl. Pharmacol. 2009, 236:372-382.
20. Gerberick G.F., Robinson M.K., Ryan C.A., Dearman R.J., Kimber I., Basketter D.A., Wright Z., Marks J.G. Contact allergenic potency: correlation of human and local lymph node assay data. Am. J. Contact Dermat. 2001, 12:156-161.
21. Girolomoni G., Sebastiani S., Albanesi C., Cavani A. T-cell subpopulations in the development of atopic and contact allergy. Curr. Opin. Immunol. 2001, 13:733-737.
22. + regulatory T cells utilize FasL as a mechanism to restrict dendritic cell priming functions in cutaneous immune responses. Eur. J. Immunol. 2010, 40:2006-2015.
23. Grabbe S., Schwarz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol. Today 1998, 19:37-44.
24. Hauser C., Katz S.I. Activation and expansion of hapten- and protein-specific T helper cells from non-sensitized mice. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:5625-5628.
25. Hostynek J.J., Maibach H.I. Thresholds of elicitation depend on induction conditions. Could low level exposure induce sub-clinical allergic states that are only elicited under the severe conditions of clinical diagnosis?. Food Chem. Toxicol. 2004, 1859-1865.
26. Jowsey I.R., Basketter D.A., Westmorelend C., Kimber I. A future approach to measuring relative skin sensitising potency: a proposal. J. Appl. Toxicol. 2006, 26:341-350.
27. + T cell-mediated contact hypersensitivity. J. Exp. Med. 1999, 189:779-786.
28. Kimber I., Basketter D.A. Contact sensitization: a new approach to risk assessment. Hum. Ecol. Risk Assess. 1997, 3:385-395.
29. Kimber I., Basketter D.A., Berthold K., Butler M., Garrigue J-L., Lea L., Newsome C., Roggeband R., Steiling W., Stropp G., Waterman S., Wiemann C. Skin sensitization testing in potency and risk assessment. Toxicol. Sci. 2001, 59:198-208.
30. Kimber I., Basketter D.A., Butler M., Gamer A., Garrigue J-L., Gerberick G.F., Newsome C., Steiling W., Vohr H.W. Classification of contact allergens according to potency: proposals. Food Chem. Toxicol. 2003, 41:1799-1809.
31. Kimber I., Basketter D.A., Gerberick G.F., Dearman R.J. Allergic contact dermatitis. Int. Immunopharmacol. 2002, 2:201-211.
32. Kimber I., Basketter D.A., Gerberick G.F., Ryan C.A., Dearman R.J. Chemical allergy: translating biology into hazard characterization. Toxicol. Sci. 2011, 120(S1):S238-S268.
33. Kimber I., Basketter D.A., Dearman R.J. Chemical allergens: what are the issues?. Toxicology 2010, 268:139-142.
34. Kimber I., Dearman R.J. Investigation of lymph node cell proliferation as a possible immunological correlate of contact sensitizing potential. Food Chem. Toxicol. 1991, 29:125-129.
35. Kimber I., Dearman R.J. Allergic contact dermatitis: the cellular effectors. Contact Dermat. 2002, 46:1-5.
36. Kimber I., Dearman R.J., Basketter D.A., Ryan C.A., Gerberick G.F. The local lymph node assay: past, present and future. Contact Dermat. 2002, 47:315-328.
37. Kimber I., Dearman R.J., Basketter D.A., Ryan C.A., Gerberick G.F., McNamee P.M., Lalko J., Api A.M. Dose metrics in the acquisition of skin sensitization: thresholds and importance of dose per unit area. Regul. Toxicol. Pharmacol. 2008, 52:39-45.
38. Kimber I., Gerberick G.F., Basketter D.A. Thresholds in contact sensitization: theoretical and practical applications. Food Chem. Toxicol. 1999, 37:553-560.
39. Kimber I., Shepherd C.J., Mitchell J.A., Turk J.L., Baker D. Regulation of lymphocyte proliferation in contact sensitivity: homeostatic mechanisms and a possible explanation of antigenic competition. Immunology 1989, 66:577-582.
40. + T cells from class II MHC-deficient mice in contact hypersensitivity responses. J. Leukoc. Biol. 2007, 82:85-92.
41. Kligman A.M. The identification of contact allergens by human assay. II. Factors influencing the induction and measurement of allergic contact dermatitis. J. Invest. Dermatol. 1966, 47:375-392.
42. Kohler J., Martin S., Pflugfelder U., Ruh H., Vollmer J., Weltzien H.U. Cross-reactive trinitrophenylated peptides as antigens for class II major histocompatibility complex-restricted T cells and inducers of contact sensitivity in mice. Limited T cell receptor repertoire. Eur. J. Immunol. 1995, 25:92-101.
43. Krasteva M., Peguet-Navarro J., Moulon C., Courtellemont P., Redziniak G., Schmitt D. In vitro primary sensitization of hapten-specific T cells by cultured human epidermal Langerhans cells - a screening predictive assay for contact sensitizers. Clin. Exp. Allergy 1996, 26:563-570.
44. + T cells. Int. Arch. Allergy Immunol. 1998, 117:194-201.
45. Loveless S.E., Api A.M., Crevel R.W., Debruyne E., Gamer A., Jowsey I.R., Kern P., Kimber I., Lea L., Lloyd P., Mehmood Z., Steiling W., Veenstra G., Woolhiser M., Hennes C. Potency values from the local lymph node assay: application to classification, labelling and risk assessment. Regul. Toxicol. Pharmacol. 2010, 58:54-66.
46. Maeda A., Schwarz A., Bullinger A., Morita A., Peritt D., Schwarz T. Experimental extracorporeal photophoresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: generation of IL-10 and induction of regulatory T cells. J. Immunol. 2008, 181:5956-5962.
47. Magnusson B., Kligman A.M. Identification of contact allergens by animal assay. The guinea pig maximisation test. J. Invest. Dermatol. 1969, 52:268-276.
48. Martin S.F. T lymphocyte-mediated immune responses to chemical haptens and metal ions: implications for allergic and autoimmune disease. Int. Arch. Allergy Immunol. 2004, 134:186-198.
49. + Tc1 cells is associated with the murine immune response to the contact sensitizer trinitrophenyl. Exp. Dermatol. 2003, 12:78-85.
50. + Tc1 cells in the immune response to the contact sensitizer trinitrophenyl. J. Immunol. 2004, 173:3178-3185.
51. Martin S.F., Esser P.R., Schmucker S., Dietz L., Naisbitt D.J., Park B.K., Vocanson M., Nicolas J.F., Keller M., Pichler W.J., Peiser M., Luch A., Wanner R., Maggi E., Cavani A., Rustemeyer T., Richter A., Thierse H.J., Sallusto F. T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays. Cell. Mol. Life Sci. 2010, 67:4171-4184.
52. Martin S.F., Esser P.R., Weber F.C., Jakob T., Freudenberg M.A., Schmidt M., Goebeler M. Mechanisms of chemical-induced innate immunity in allergic contact dermatitis. Allergy 2011, 66:1152-1163.
53. + T cells are the dominant effector cells in trinitrophenyl-specific contact hypersensitivity. J. Invest. Dermatol. 2000, 115:260-266.
54. Martin S., Ortmann B., Pflugfelder U., Birsner U., Weltzien H.U. Role of hapten-anchoring peptides in defining hapten epitopes for MHC restricted cytotoxic T cells. Cross-reactive TNP-determinants on different peptides. J. Immunol. 1992, 149:2569-2575.
55. Martin S., von Bonin A., Fessler C., Pflugfelder U., Weltzien H.U. Structural complexity of antigenic determinants for class I MHC-restricted, hapten-specific T cells. Two qualitatively differing types of H-2 Kb-restricted TNP epitopes. J. Immunol. 1993, 151:678-687.
56. Martin-Fontecha A., Sebastiani S., Hopken U.E., Uguccioni M., Lipp M., Lanzavecchia A., Sallusto F. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 2003, 198:615-621.
57. Moulon C., Peguet-Navarro J., Courtellemont P., Redziniak G., Schmitt D. In vitro primary sensitization and restimulation of hapten-specific T cells by fresh and cultured human epidermal Langerhans cells. Immunology 1993, 80:373-379.
58. + cytotoxic T cells from allergic donors. J. Invest. Dermatol. 1998, 111:360-366.
59. Ortmann B., Martin S., von Bonin A., Schilz E., Hoschutzky H., Weltzien H.U. Synthetic peptides anchor T cell-specific TNP epitopes to MHC antigens. J. Immunol. 1992, 148:1445-1450.
60. + T cells. Science 2010, 327:1098-1102.
61. Romagnani S. Regulation of the T cell response. Clin. Exp. Allergy 2006, 36:1357-1366.
62. Rubin I.M., Dabelsteen S., Nielsen M.M., White I.R., Johansen J.D., Geiser C., Bonefeld C.M. Repeated exposure to hair dye induces regulatory T cells in mice. Br. J. Dermatol. 2010, 163:992-998.
63. Rustemeyer T., De Ligter S., von Blomberg B.M., Frosch P.J., Scheper R.J. Human T lymphocyte priming in vitro by haptenated autologous dendritic cells. Clin. Exp. Immunol. 1999, 117:209-216.
64. Rustemeyer T., Van Hoogstraten I.M.W., Von Blomberg B.M.E., Scheper R.J. Mechanisms of allergic contact dermatitis. Contact Dermatitis 2006, 11-43. Springer, Berlin. 4th edition. P.J. Frosch, T. Menne, J.-P. Lepoittevin (Eds.).
65. Schneider K., Akkam Z. Quantitative relationship between the local lymph node assay and human sensitization assays. Regul. Toxicol. Pharmacol. 2004, 39:245-255.
66. Schwarz A., Maeda A., Wild M.K., Kernebeck K., Gross N., Aragane Y., Beissert S., Vestweber D., Schwarz T. Ultraviolet radiation-induced regulatory T cells not only inhibit the induction, but also can suppress the effector phase of contact hypersensitivity. J. Immunol. 2004, 172:1036-1943.
67. + T regulatory cell-mediated suppression. Immunity 2009, 30:636-645.
68. Trautmann A., Adkis M., Brocker E-B., Blaser K., Adkis C.A. New insights into the role of T cells in atopic dermatitis and allergic contact dermatitis. Trends Immunol. 2001, 22:530-532.
69. Vandebriel R.J., Van Loveren H. Non-animal sensitization testing: state-of-the-art. Crit. Rev. Toxicol. 2010, 40:389-404.
70. Vignali D. How many mechanisms do regulatory T cells need?. Eur. J. Immunol. 2008, 38:908-911.
71. + cells allows for the sensitive in vitro screening of contact allergens. J. Invest. Dermatol. 2008, 128:2119-2122.
72. Vocanson M., Hennino A., Rozieres A., Poyet G., Nicolas J.-F. Effector and regulatory mechanisms in allergic contact dermatitis. Allergy 2009, 64:1699-1714.
73. Vocanson M., Rozieres A., Hennino A., Povet G., Gaillard V., Renaudineau S., Achachi A., Benetiere J., Kaiserlian D., Dubois B., Nicolas J-F. Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH1/TH17 and regulatory T cells. J. Allergy Clin. Immunol. 2010, 126:280-289.
74. Warbrick E.V., Dearman R.J., Lea L.J., Basketter D.A., Kimber I. Local lymph node assay responses to paraphenylene diamine: intra- and inter-laboratory studies. J. Appl. Toxicol. 1999, 19:225-260.
75. White S.I., Friedmann P.S., Moss C., Simpson J.M. The effect of altering the area of application and dose per unit area on sensitization by DNCB. Br. J. Dermatol. 1986, 115:663-668.
76. + T cells. J. Exp. Med. 1996, 183:1001-1012.